Skip to Main Content
CWRU Links

2012 Articles

January 3, 2012

Date Released: 3 January 2012
News Banner


Mammograms Go 3-D
KSDK - Jan 2, 2011
Tomosynthesis allows radiologist Donna Plecha to get a more detailed view. Instead of the standard four images from the x-ray, she's seeing about 200. ...

Cleveland Clinic Researcher Discovers Genetic Cause of Thyroid Cancer - Dec 27, 2011
Research led by Charis Eng, MD, PhD, Chair and founding Director of the Genomic Medicine Institute of Cleveland Clinic's Lerner Research Institute, ...

Skin Cancer More Likely After First Malignancy
MedPage Today - Dec 20, 2011
... 45 and older after a first primary cancer, Jeremy S. Bordeaux, MD, MPH, of University Hospitals Case Medical Center in Cleveland, and colleagues found. ...

Breast Cancer Awareness All Year: NetWellness
Plain Dealer - Dec 20, 2011
This week's NetWellness column is by Dr. Paula Silverman, associate professor of Medicine, School of Medicine, Case Western Reserve University There are ...

Healing From Cancer Tops Family's Christmas List
Guilford County Northwest Observer - Dec 16, 2011
"There has been significant progress in the treatment of glioblastoma," says Andrew Sloan, MD, director of the Brain Tumor and Neuro-oncology Center at University Hospitals Case Medical Center in Cleveland...


Special Cancer Center Seminar Series: RB-pathway in Translation: Significance to Breast Cancer Treatment

Erik Knudsen, PhDTuesday, January 3
4-5 pm
Wolstein Research Building 2-136

Please join us today, January 3, at 4 pm in Wolstein 2-136 for a special seminar titled RB-pathway in Translation: Significance to Breast Cancer Treatment, presented by Erik Knudsen, PhD. Dr. Knudsen is the Deputy Director for Basic Research at the Kimmel Cancer Center and Professor of Cancer Biology at Thomas Jefferson University. He has made significant contributions to our understanding of tumor suppressor function, with particular emphasis on RB in various cancers. Most recently, he has delineated a role for RB in regulating therapeutic responsiveness of breast cancer. Among his many accomplishments are membership on the Editorial Board for "Cancer Research" and he has recently chaired the Tumor Cell Biology Study Section. He has also published over 100 primary research articles. In his seminar, Dr. Knudsen will share his most recent insights regarding the use of RB status as a predictor for therapeutic response in breast cancer.

NCI Second Symposium on Translational Genomics

Registration is now open for the Second Symposium on Translational GenomicsMarch 15-16 at the NIH in Bethesda, Maryland. Presented by the NCI Center of Excellence in Integrative Cancer Biology and Genomics, this seminar will provide a dedicated forum for the advancement, implementation, and exchange of information on noncoding RNAs, next generation sequencing, and epigenomics and genetic variation for translation into clinical practice, with the ultimate goal to improve the health of patients with cancer.


NIH Establishes National Center for Advancing Translational Sciences

In a move to re-engineer the process of translating scientific discoveries into new drugs, diagnostics, and devices, the National Institutes of Health has established the National Center for Advancing Translational Sciences (NCATS). The action was made possible by Congress' approval of a fiscal year 2012 spending bill and the president's signing of the bill, which includes the establishment of NCATS with a budget of $575 million.

NCATS will serve as the nation's hub for catalyzing innovations in translational science. Working closely with partners in the regulatory, academic, nonprofit, and private sectors, NCATS will strive to identify and overcome hurdles that slow the development of effective treatments and cures.


New Members

Please join us in welcoming the newest members of the Case CCC:

Ramon Tiu, MD
Assistant Professor, Translational Hematology and Oncology Research
Hematopoietic Disorders Program

Carl Tyler, MD
Associate Professor, Family Medicine
Cancer Prevention, Control and Population Research Program

Vikas Gulani, MD, PhD
Assistant Professor, Radiology
Cancer Imaging Program

Efstathios Karathanasis, PhD
Assistant Professor, Biomedical Engineering and Radiology
Cancer Imaging Program

Justin Lathia, PhD
Research Associate, Stem Cell Biology and Regenerative Medicine
Cancer Cell Signaling Program

Sonja Harris-Haywood, MD
Assistant Professor, Family Medicine
Cancer Prevention, Control and Population Research Program

Cancer Center Members Recognized for Contributions to Science and Technology by AAAS

In November 2011, 539 individuals were elected as Fellows of the American Association for the Advancement of Science (AAAS). The Case CCC is honored to have three researchers from our institutions recognized for their contributions to science and technology: Xiaoxia Li and Michael Ledermanfor Medical Sciences and Bruce Lamb for Neuroscience.


American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Annual Meeting Merit Awards

The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) offers Merit Awards to trainees who submit high-quality abstracts selected for presentation at an ASCO Meeting. To be considered for a Merit Award, the first author of an abstract must be a physician (MD, PharmD, PhD, DO, or other doctoral degree) enrolled in an oncology training program at the time of abstract submission, work in an oncology laboratory or clinical research setting, and agree to present the abstract at the ASCO Annual Meeting. Candidates must apply for this award at the time of abstract submission.
Deadline: February 1

Damon Runyon-Sohn Pediatric Cancer Fellowship Award

The Damon Runyon Cancer Research Foundation has joined together with the Sohn Conference Foundation, dedicated to curing pediatric cancers, to establish the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers. Only one fellowship application will be accepted from a Sponsor or Fellow per review session; there is no limit, however, to the number of applications from an institution.
Deadline: March 15



**All events are open to anyone interested in attending

January 2

Happy New Year!

January 3

Special Cancer Center Seminar Series
Erik Knudsen, PhD
Deputy Director for Research
Professor, Cancer Biology
Kimmel Cancer Center/Thomas Jefferson University
Topic: RB-pathway in Translation: Significance to Breast Cancer Treatment
4 pm WRB 2-136

January 4

Hematology and Oncology Division Research Conference
Paula Silverman, MD
Associate Professor, Div. of Hem/Onc
Ashley Rosko, MD
Fellow, Div. of Hem/Onc
Lan Zhou, MD, PhD
Assistant Professor, Pathology
Topic: Addressing Systematic Errors and Delays: A Case Discussion
8 am Lerner Tower B-151

January 5

Molecular Biology & Microbiology Seminar
Susann Brady-Kalnay, PhD
Professor, Molecular Biology & Microbiology
Topic: PTPmu as a Therapeutic Target in Brain Tumors
Susan Burden-Gulley, PhD
Senior Research Associate, Brady-Kalnay Lab, Molecular Biology & Microbiology
Topic: Molecular Imaging of Dispersing Brain Tumor Cells
1 pm Rottman Seminar Rm. W203

January 6

Cancer Center Seminar Series canceled

Hem/Onc Fellows Conference
Anita Schwandt, MD
Fellow, Div. of Hem/Onc
Topic: TBD
8 am Wearn 137

Taussig Cancer Institute Grand Rounds
Mellar Davis, MD
Professor, Hematology & Medical Oncology
CWRU/Cleveland Clinic
Topic: Fatigue in Cancer: What are the Mechanisms?
Patrick Ma, MD
Assistant Professor, Translational Hematology and Oncology Research
CWRU/Cleveland Clinic
Topic: MET Targeting Personalized Lung Cancer Therapy
8 am R3/002-003 Cleveland Clinic

CAP Promotion Seminar
Takao Sakai, PhD
Assistant Professor, Biomedical Engineering
CWRU/Cleveland Clinic
Topic: Interdependence of Cell and Extracellular Matrix on Adult Tissue Repair
11 am NA1-142 Cleveland Clinic

Cancer Center Research in Progress Seminar
Molly Taylor
Graduate Student, Schiemann Lab, Div. of General Medical Sciences-Oncology
Topic: The Role of microRNA-181a in TGF-beta Mediated Breast Cancer Progression
4 pm WRB 3-316

Case CCC Calendar

LRI Calendar


Special Seminar
January 19
Jacques Galipeau, MD, FRCP(C)
Professor, Hematology and Medical Oncology & Pediatrics
Emory University Winship Cancer Institute
Topic: Mesenchymal Stromal Cell Suppression of Autoimmune Response. From Discovery to Design of Cell Therapy Studies
12 pm Wearn 137


Berman Lecture/Department of Medicine Grand Rounds
January 17
Max Wicha, MD
Director, University of Michigan Comprehensive Cancer Center
Distinguished Professor of Oncology
Professor, Internal Medicine
University of Michigan
Topic: Clinical Implications of Cancer Stem Cells
12 pm Kulas Auditorium

Department of Biomedical Engineering Special Seminar
May 3
Steve Zullo, PhD
Program Director, Division of Discovery Science and Technology
National Institute of Biomedical Imaging and Bioengineering, NIH
Topic: NIH Grant Machine Revealed, Not a Black Box Anymore
12 pm Wickenden 509


National Center of Regenerative Medicine (NCRM) Stem Cell-related Pilot Projects
Deadline: December 21

ASCO Resident Travel Award
Deadline: January 09, 2012

Society of Surgical Oncology 2012 Clinical Investigator Awards
Deadline: January 9, 2012

AACR-Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway
Deadline: January 10, 2012

AACR Judah Folkman Career Development Award for Antiangiogenesis Research
Deadline: January 10, 2012

Beez Foundation
Deadline: January 10, 2012

Lymphatic Research Foundation (LRF) Postdoctoral Fellowship Program
Deadline: January 10, 2012

AACR Clinical and Translational Cancer Research Fellowships
Deadline: January 11, 2012

HHMI Medical Research Fellows Program
Deadline: January 11, 2012

SAIC-Frederick Support of the Cancer Genome Atlas Program
Deadline: January 13, 2012

CTSC Annual Pilot Grant Funding
Mandatory LOI Deadline: January 15, 2012

Oncology Nursing Society Foundation Connie Henke Yarbro Excellence in Cancer Nursing Mentorship Award
Deadline: January 15, 2012

Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research
Deadline: January 17, 2012

Fight Colorectal Cancer-AACR Career Development Award, in memory of Lisa Dubow
Deadline: January 17, 2012

Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research
Deadline: January 18, 2012

Robert Wood Johnson Foundation Executive Nurse Fellows
Deadline: January 18, 2012

Children's Tumor Foundation Young Investigator Award Program
Pre-Application Deadline: January 27, 2012
Application Deadline: April 2, 2012

Sarcoma Foundation of America (SFA)
Deadline: January 31, 2012

2012 Lasker Awards
Deadline: February 1, 2012

Oncology Nursing Foundation
Deadline: February 1, 2012

Lymphatic Research Foundation (LRF)
Deadline: February 3, 2012

Innovations for Health: Solutions that Cross Borders
Deadline: February 13, 2012

Advancing Health Services through System Modeling Research
Deadline: February 15, 2012

Ohio Cancer Research Associates
Deadline: February 17, 2012

Robert Wood Johnson Foundation Clinical Scholars Program
Deadline: February 29, 2012

Leukemia & Lymphoma Society Translational Research Program
LOI Deadline: March 1, 2012
Full Application Deadline: March 15, 2012

Childhood Brain Tumor Foundation (CBTF)
Deadline: March 12, 2012

James S. McDonnell Foundation 21st Century Research Awards
Deadline: March 14, 2012

Irvington Institute Fellowship Program
Deadline: April 1, 2012

Wendy Will Case Cancer Fund
Deadline: April 1, 2012

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open

NIH BULLETIN – Notices and Funding Opportunities

Small Grants for Behavioral Research in Cancer Control (R03)(PAR-12-035)

The NCI Transition Career Development Award to Promote Diversity (K22)(PAR-12-062)

NCI Established Investigator Award in Cancer Prevention and Control (K05)(PAR-12-065)

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)(PAR-12-067)

Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D43)(PAR-12-068)

Early-Stage Innovative Technology Development for Cancer Research (R21) (RFA-CA-12-002)

Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)(RFA-CA-12-003)

Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)(RFA-CA-12-004)

Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)(RFA-CA-12-005)

Notice of Two Pilot Processes for Submitting Administrative Supplement Requests Electronically to NIH (NOT-OD-12-024)

Innovative Molecular Analysis Technologies (IMAT) for Cancer Research Selection of Appropriate Funding Opportunity (NOT-CA-12-006)

Extension of Expiration Date for NCI Funding Opportunity Announcement PAR-09-089: The NCI Transition Career Development Award (K22) (NOT-CA-12-010)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax


If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to